Format

Send to

Choose Destination
See comment in PubMed Commons below
Bol Asoc Med P R. 2013;105(2):47-53.

The cardiology and endocrinology connection between amiodarone and thyrotoxicosis: case report and review of the literature.

Author information

1
Internal Medicine and Endocrinology Department, San Juan City Hospital, San Juan Puerto Rico. coropalermo@caribe.net

Abstract

Amiodarone is used in a large number of cardiac conditions. Amiodarone-induced thyroid dysfunction has been reported to affect up to 20% of users. Amiodarone can lead to both amiodarone-induced hypothyroidism (AIH) and less commonly amiodarone-induced thyrotoxicosis (AIT). There are two main forms of AIT. Type 1 AIT, a form of io-dine-induced hyperthyroidism, and type 2, a drug-induced destructive thyroiditis. Type 1 AIT develops on individuals with underlying thyroid disease. Treatment of Type 1 AIT includes the use of antithyroid drugs and discontinuation of amiodarone. Type 2 AIT is commonly self-limiting in nature. In this article wedescribe a patient with Amiodarone-induced thyrotoxicosis discussing its clinical features and medical therapeutic approach.

PMID:
23882990
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center